Mdm2 and Crem are associated with glioma, leukemia, prostate cancer, chronic myeloid leukemia, and several other cancer pathways, whereas, Gsk3b is an antitumor gene associated with prostate cancer (Table S3). The gene discussed is MDM2; the disease is prostate carcinoma.